• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-1224-5p 通过靶向 SND1 抑制卵巢癌细胞的增殖和侵袭。

miR-1224-5p inhibits the proliferation and invasion of ovarian cancer via targeting SND1.

机构信息

Department of Obstetrics and Gynecology, China-Japan Union Hospital of Jilin University, Changchun, 130033, Jilin, People's Republic of China.

Department of Anesthesiology, China-Japan Union Hospital of Jilin University, Changchun, 130033, Jilin, People's Republic of China.

出版信息

Hum Cell. 2020 Jul;33(3):780-789. doi: 10.1007/s13577-020-00364-4. Epub 2020 May 14.

DOI:10.1007/s13577-020-00364-4
PMID:32409958
Abstract

Emerging evidences have indicated that abnormal expression of microRNAs (miRNAs) contributed to carcinogenesis of ovarian cancer. However, the molecular mechanism of many aberrant expressed miRNAs was not known. Here, we discovered that miR-1224-5p was a downregulated miRNA in ovarian cancer via bioinformatic analysis and RT-qPCR. It was found that upregulation of miR-1224-5p inhibited cell proliferation and invasion ability of ovarian cancer cells. SND1, a well-characterized oncogene, was predicted as a target gene of miR-1224-5p. The western blotting, dual luciferase reporter assay, RNA-binding protein immunoprecipitation assay, and RT-qPCR demonstrated SND1 as a target gene of miR-1224-5p in ovarian cancer. MiR-1224-5p inhibited the expression of mesenchymal markers and increased the expression of epithelial markers in ovarian cancer cells via targeting SND1, indicating miR-1224-5p was involved in epithelial mesenchymal transition. The rescue assay manifested that miR-1224-5p-regulated cell proliferation and invasion mainly rely on downregulation of SND1 in ovarian cancer cells. In conclusion, our study revealed a direct regulatory association between miR-1224-5p and SND1 and their involvement in ovarian carcinogenesis.

摘要

已有研究表明,微小 RNA(miRNAs)的异常表达与卵巢癌的发生有关。然而,许多异常表达的 miRNA 的分子机制尚不清楚。在这里,我们通过生物信息学分析和 RT-qPCR 发现 miR-1224-5p 在卵巢癌中呈下调表达。研究发现,上调 miR-1224-5p 抑制了卵巢癌细胞的增殖和侵袭能力。SND1 是一种公认的癌基因,被预测为 miR-1224-5p 的靶基因。Western blot、双荧光素酶报告基因检测、RNA 结合蛋白免疫沉淀实验和 RT-qPCR 均证实 SND1 是卵巢癌细胞中 miR-1224-5p 的靶基因。miR-1224-5p 通过靶向 SND1 抑制了卵巢癌细胞中间充质标志物的表达,增加了上皮标志物的表达,表明 miR-1224-5p 参与了上皮间质转化。挽救实验表明,miR-1224-5p 调控卵巢癌细胞的增殖和侵袭主要依赖于 SND1 的下调。综上所述,本研究揭示了 miR-1224-5p 与 SND1 之间的直接调控关系及其在卵巢癌发生中的作用。

相似文献

1
miR-1224-5p inhibits the proliferation and invasion of ovarian cancer via targeting SND1.miR-1224-5p 通过靶向 SND1 抑制卵巢癌细胞的增殖和侵袭。
Hum Cell. 2020 Jul;33(3):780-789. doi: 10.1007/s13577-020-00364-4. Epub 2020 May 14.
2
UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.UBE2C 被 miR-548e-5p 直接靶向,增加了与非小细胞肺癌中 EMT 标志物蛋白锌指 E-box 结合同源框 1/2 相互作用的癌细胞的细胞生长和侵袭能力。
Theranostics. 2019 Mar 17;9(7):2036-2055. doi: 10.7150/thno.32738. eCollection 2019.
3
MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2.miR-219-5p 通过靶向 HMGA2 抑制卵巢癌细胞的生长和转移。
Biol Res. 2018 Nov 24;51(1):50. doi: 10.1186/s40659-018-0199-y.
4
[MiR-125b-5 suppresses ovarian cancer cell migration and invasion by targeted downregulation of CD147].[微小RNA-125b-5通过靶向下调CD147抑制卵巢癌细胞的迁移和侵袭]
Nan Fang Yi Ke Da Xue Xue Bao. 2022 Sep 20;42(9):1389-1396. doi: 10.12122/j.issn.1673-4254.2022.09.16.
5
miR-744-5p inhibits cellular proliferation and invasion via targeting ARF1 in epithelial ovarian cancer.miR-744-5p 通过靶向 ARF1 抑制上皮性卵巢癌中的细胞增殖和侵袭。
Kaohsiung J Med Sci. 2020 Oct;36(10):799-807. doi: 10.1002/kjm2.12253. Epub 2020 Jun 17.
6
SND1 acts as a functional target of miR-330-5p involved in modulating the proliferation, apoptosis and invasion of colorectal cancer cells.SND1 作为 miR-330-5p 的功能靶标,参与调节结直肠癌细胞的增殖、凋亡和侵袭。
Biochem Biophys Res Commun. 2022 Jul 30;615:116-122. doi: 10.1016/j.bbrc.2022.05.045. Epub 2022 May 14.
7
lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR.长链非编码 RNA MEG3 通过海绵吸附 miR-219a-5p 并调节 EGFR 来修饰卵巢癌细胞的上皮-间充质转化。
J Cell Biochem. 2019 Oct;120(10):17709-17722. doi: 10.1002/jcb.29037. Epub 2019 Jun 3.
8
miR-339-5p inhibits migration and invasion in ovarian cancer cell lines by targeting NACC1 and BCL6.微小RNA-339-5p通过靶向NACC1和BCL6抑制卵巢癌细胞系的迁移和侵袭。
Tumour Biol. 2016 Apr;37(4):5203-11. doi: 10.1007/s13277-015-4390-2. Epub 2015 Nov 9.
9
miRNA-296-5p functions as a potential tumor suppressor in human osteosarcoma by targeting SND1.miRNA-296-5p 通过靶向 SND1 在人骨肉瘤中发挥潜在的肿瘤抑制作用。
Chin Med J (Engl). 2021 Feb 9;134(5):564-572. doi: 10.1097/CM9.0000000000001400.
10
MicroRNA-219-5p inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells by targeting the Twist/Wnt/β-catenin signaling pathway.微小RNA-219-5p通过靶向Twist/Wnt/β-连环蛋白信号通路抑制上皮性卵巢癌细胞的增殖、迁移和侵袭。
Gene. 2017 Dec 30;637:25-32. doi: 10.1016/j.gene.2017.09.012. Epub 2017 Sep 7.

引用本文的文献

1
Signaling networks and MiRNA crosstalk in ovarian cancer chemoresistance.卵巢癌化疗耐药中的信号网络与微小RNA相互作用
J Ovarian Res. 2025 Aug 14;18(1):185. doi: 10.1186/s13048-025-01770-8.
2
circPOLA2 promotes proliferation, invasion, migration, and epithelial-mesenchymal transition in breast cancer via the miR-1224-5p/HMGA2 axis.环状POLA2通过miR-1224-5p/HMGA2轴促进乳腺癌的增殖、侵袭、迁移和上皮-间质转化。
Clinics (Sao Paulo). 2025 Apr 23;80:100653. doi: 10.1016/j.clinsp.2025.100653. eCollection 2025.
3
[Identification and Analysis of SND1 as an Oncogene and Prognostic Biomarker 
for Lung Adenocarcinoma].

本文引用的文献

1
Linc00460 promotes osteosarcoma progression via miR-1224-5p/FADS1 axis.Linc00460 通过 miR-1224-5p/FADS1 轴促进骨肉瘤进展。
Life Sci. 2019 Sep 15;233:116757. doi: 10.1016/j.lfs.2019.116757. Epub 2019 Aug 13.
2
In silico analysis identified miRNA‑based therapeutic agents against glioblastoma multiforme.通过计算机分析鉴定了针对多形性胶质母细胞瘤的 miRNA 治疗药物。
Oncol Rep. 2019 Apr;41(4):2194-2208. doi: 10.3892/or.2019.7022. Epub 2019 Feb 19.
3
Long non-coding RNA ZEB1-AS1 indicates poor prognosis and promotes melanoma progression through targeting miR-1224-5p.
[鉴定与分析SND1作为肺腺癌的癌基因和预后生物标志物]
Zhongguo Fei Ai Za Zhi. 2024 Jan 20;27(1):25-37. doi: 10.3779/j.issn.1009-3419.2023.102.47.
4
Circ_0000115 Protects Against Cerebral Ischemia Injury by Suppressing Neuronal Apoptosis, Oxidative Stress and Inflammation by miR-1224-5p/Nos3 Axis In Vitro.Circ_0000115 通过 miR-1224-5p/Nos3 轴体外抑制神经元凋亡、氧化应激和炎症来保护脑缺血损伤。
Mol Biotechnol. 2024 May;66(5):1082-1094. doi: 10.1007/s12033-023-01005-5. Epub 2023 Dec 27.
5
Plasma-derived exosomal miRNA profiles reveal potential epigenetic pathogenesis of premature ovarian failure.血浆衍生的外泌体 miRNA 谱揭示了卵巢早衰潜在的表观遗传发病机制。
Hum Genet. 2024 Oct;143(9-10):1021-1034. doi: 10.1007/s00439-023-02618-1. Epub 2023 Dec 6.
6
Proteomic Discovery of Plasma Protein Biomarkers and Development of Models Predicting Prognosis of High-Grade Serous Ovarian Carcinoma.血浆蛋白质生物标志物的蛋白质组学发现和预测高级别浆液性卵巢癌预后模型的建立。
Mol Cell Proteomics. 2023 Mar;22(3):100502. doi: 10.1016/j.mcpro.2023.100502. Epub 2023 Jan 17.
7
Inhibition of miR-141-3p attenuates apoptosis of neural stem cells via targeting PBX1 to regulate PROK2 transcription in MCAO mice.抑制 miR-141-3p 通过靶向 PBX1 调节 PROK2 转录来减轻 MCAO 小鼠神经干细胞凋亡。
Cell Cycle. 2023 Feb;22(4):403-418. doi: 10.1080/15384101.2022.2121358. Epub 2022 Dec 22.
8
Long Non-coding RNA SPAG5-AS1 Attenuates Diabetic Retinal Vascular Dysfunction by Inhibiting Human Retinal Microvascular Endothelial Cell Proliferation, Migration, and Tube Formation by Regulating the MicroRNA-1224-5p/IRS-1 Axis.长链非编码 RNA SPAG5-AS1 通过调控 microRNA-1224-5p/IRS-1 轴抑制人视网膜微血管内皮细胞增殖、迁移和管腔形成来减轻糖尿病视网膜血管功能障碍。
Mol Biotechnol. 2023 Jun;65(6):904-912. doi: 10.1007/s12033-022-00572-3. Epub 2022 Nov 8.
9
Inflammation and Oxidative Stress Role of S100A12 as a Potential Diagnostic and Therapeutic Biomarker in Acute Myocardial Infarction.炎症和氧化应激:S100A12 作为急性心肌梗死潜在诊断和治疗生物标志物的作用。
Oxid Med Cell Longev. 2022 Aug 25;2022:2633123. doi: 10.1155/2022/2633123. eCollection 2022.
10
The Role and Mechanism of microRNA-1224 in Human Cancer.微小RNA-1224在人类癌症中的作用及机制
Front Oncol. 2022 Apr 14;12:858892. doi: 10.3389/fonc.2022.858892. eCollection 2022.
长链非编码RNA ZEB1-AS1提示预后不良,并通过靶向miR-1224-5p促进黑色素瘤进展。
Exp Ther Med. 2019 Jan;17(1):857-862. doi: 10.3892/etm.2018.7005. Epub 2018 Nov 23.
4
SND1 acts upstream of SLUG to regulate the epithelial-mesenchymal transition (EMT) in SKOV3 cells.SND1 通过调控 SKOV3 细胞上皮间质转化(EMT)在上游调控 SLUG。
FASEB J. 2019 Mar;33(3):3795-3806. doi: 10.1096/fj.201801728R. Epub 2018 Dec 3.
5
Integrated extracellular microRNA profiling for ovarian cancer screening.用于卵巢癌筛查的整合细胞外 microRNA 分析。
Nat Commun. 2018 Oct 17;9(1):4319. doi: 10.1038/s41467-018-06434-4.
6
SND1 expression in breast cancer tumors is associated with poor prognosis.SND1 在乳腺癌肿瘤中的表达与不良预后相关。
Ann N Y Acad Sci. 2018 Dec;1433(1):53-60. doi: 10.1111/nyas.13970. Epub 2018 Sep 14.
7
Integrated microarray meta-analysis identifies miRNA-27a as an oncogene in ovarian cancer by inhibiting FOXO1.综合微阵列荟萃分析确定 miRNA-27a 通过抑制 FOXO1 成为卵巢癌的致癌基因。
Life Sci. 2018 Oct 1;210:263-270. doi: 10.1016/j.lfs.2018.08.043. Epub 2018 Aug 20.
8
LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression.长链非编码 RNA PTAR 通过竞争性结合 miR-101-3p 调控 ZEB1 表达促进浆液性卵巢癌中的 EMT 和侵袭转移。
Mol Cancer. 2018 Aug 11;17(1):119. doi: 10.1186/s12943-018-0870-5.
9
MiR-630 promotes epithelial ovarian cancer proliferation and invasion via targeting KLF6.miR-630 通过靶向 KLF6 促进卵巢上皮性癌细胞的增殖和侵袭。
Eur Rev Med Pharmacol Sci. 2017 Oct;21(20):4542-4547.
10
Diagnostic potential for a serum miRNA neural network for detection of ovarian cancer.血清 miRNA 神经网络在卵巢癌检测中的诊断潜力。
Elife. 2017 Oct 31;6:e28932. doi: 10.7554/eLife.28932.